ARHGDIA and breast carcinoma: Although the detailed mechanisms remain to be determined, RhoGDI deficiency promotes breast cancer growth at least partly through activation of Rho GTPases and subsequent upregulation of COX-2 signaling (see illustration in Fig. 7).